ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2015 to Q2 2024

Type / Class
Equity / COM
Symbol
ZYNE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$16,233 0
2024 Q1 12,732 $16,233 +$16,233 $1.28 1
2023 Q4 0 $0 -$14,377,093 0
2023 Q3 11,381,644 $14,504,093 +$11,021,781 $1.28 40
2023 Q2 5,329,822 $1,736,442 -$121,351 $0.33 37
2023 Q1 6,401,197 $2,751,572 -$704,545 $0.43 38
2022 Q4 7,985,704 $4,232,539 -$1,798,848 $0.53 43
2022 Q3 10,882,502 $7,963,000 -$88,102 $0.73 45
2022 Q2 10,977,093 $12,541,000 -$1,436,742 $1.14 42
2022 Q1 11,698,232 $24,349,000 -$2,936,395 $2.05 45
2021 Q4 13,259,717 $38,324,792 -$1,482,594 $2.88 50
2021 Q3 13,518,561 $57,137,000 -$5,893,499 $4.24 48
2021 Q2 14,645,548 $78,066,297 +$30,126,763 $5.29 58
2021 Q1 9,042,819 $42,040,702 +$12,361,283 $4.65 57
2020 Q4 6,461,345 $21,327,053 +$3,398,259 $3.30 50
2020 Q3 5,453,369 $18,046,053 -$7,045,445 $3.31 58
2020 Q2 7,599,925 $25,612,341 -$6,003,706 $3.37 70
2020 Q1 9,209,680 $35,277,813 -$6,501,402 $3.83 68
2019 Q4 10,739,510 $64,832,529 -$1,755,196 $6.04 77
2019 Q3 10,459,953 $79,081,247 +$14,507,188 $7.56 77
2019 Q2 8,519,069 $115,312,746 +$86,077,760 $13.55 68
2019 Q1 2,303,313 $12,479,756 -$63,774 $5.42 50
2018 Q4 2,705,841 $8,035,058 -$3,208,497 $2.97 52
2018 Q3 2,905,101 $23,695,843 +$2,982,868 $8.16 60
2018 Q2 2,491,381 $24,260,162 -$4,267,020 $9.74 58
2018 Q1 2,982,498 $25,918,457 -$11,768,279 $8.69 58
2017 Q4 3,902,750 $48,856,444 +$5,725,598 $12.52 61
2017 Q3 3,488,062 $29,160,723 -$19,023,663 $8.36 64
2017 Q2 4,535,836 $76,981,825 +$13,306,834 $16.97 63
2017 Q1 3,508,502 $70,462,026 +$18,617,431 $20.10 58
2016 Q4 2,077,650 $32,385,016 +$1,424,765 $15.59 31
2016 Q3 2,014,274 $26,288,013 +$58,310 $13.05 20
2016 Q2 2,187,688 $14,984,007 -$4,829,932 $6.85 23
2016 Q1 2,760,940 $26,089,539 +$264,194 $9.45 29
2015 Q4 2,702,054 $27,206,222 +$2,344,234 $10.07 30
2015 Q3 2,380,942 $34,070,158 +$34,070,135 $14.31 21